A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design

BACKGROUND: No drug treatment to date has shown convincing clinical evidence of restoring cognitive function or preventing further decline after stroke. The ongoing ARTEMIDA study will evaluate the efficacy and safety of Actovegin for the symptomatic treatment of post-stroke cognitive impairment (PS...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Guekht, Alla, Skoog, Ingmar, Korczyn, Amos D., Zakharov, Vladimir, Eeg, Martin, Vigonius, Ulf
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: S. Karger AG 2013
Onderwerpen:
Original Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3919431/
https://ncbi.nlm.nih.gov/pubmed/24516413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000357122
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items